FR2201287B1 - - Google Patents

Info

Publication number
FR2201287B1
FR2201287B1 FR7234136A FR7234136A FR2201287B1 FR 2201287 B1 FR2201287 B1 FR 2201287B1 FR 7234136 A FR7234136 A FR 7234136A FR 7234136 A FR7234136 A FR 7234136A FR 2201287 B1 FR2201287 B1 FR 2201287B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7234136A
Other languages
French (fr)
Other versions
FR2201287A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7234136A priority Critical patent/FR2201287A1/fr
Publication of FR2201287A1 publication Critical patent/FR2201287A1/fr
Application granted granted Critical
Publication of FR2201287B1 publication Critical patent/FR2201287B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D301/00—Preparation of oxiranes
    • C07D301/02—Synthesis of the oxirane ring
    • C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/19—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic hydroperoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7234136A 1972-09-27 1972-09-27 Epoxidation using hexafluoroacetone hydroperoxide - for treatment of unsatd. cyclic cpds esp steroids Granted FR2201287A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7234136A FR2201287A1 (en) 1972-09-27 1972-09-27 Epoxidation using hexafluoroacetone hydroperoxide - for treatment of unsatd. cyclic cpds esp steroids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7234136A FR2201287A1 (en) 1972-09-27 1972-09-27 Epoxidation using hexafluoroacetone hydroperoxide - for treatment of unsatd. cyclic cpds esp steroids

Publications (2)

Publication Number Publication Date
FR2201287A1 FR2201287A1 (en) 1974-04-26
FR2201287B1 true FR2201287B1 (enExample) 1976-03-12

Family

ID=9104826

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7234136A Granted FR2201287A1 (en) 1972-09-27 1972-09-27 Epoxidation using hexafluoroacetone hydroperoxide - for treatment of unsatd. cyclic cpds esp steroids

Country Status (1)

Country Link
FR (1) FR2201287A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2423486A1 (fr) * 1978-04-19 1979-11-16 Roussel Uclaf Nouveau reactif d'epoxydation
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
IL119649A (en) * 1995-11-30 2002-03-10 Akzo Nobel Nv Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
US10919929B2 (en) 2013-12-11 2021-02-16 Sloan-Kettering Institute For Cancer Research Glucocorticoid inhibitors for treatment of prostate cancer

Also Published As

Publication number Publication date
FR2201287A1 (en) 1974-04-26

Similar Documents

Publication Publication Date Title
FR2183008B1 (enExample)
JPS507582A (enExample)
FR2201287B1 (enExample)
FR2185421A1 (enExample)
JPS4954437A (enExample)
JPS5234826Y2 (enExample)
JPS5328603Y2 (enExample)
JPS5216013Y2 (enExample)
JPS555056B2 (enExample)
JPS4961368A (enExample)
JPS5039950Y2 (enExample)
JPS5320665Y2 (enExample)
JPS5321391Y2 (enExample)
JPS551279B2 (enExample)
JPS4978464U (enExample)
CS159525B1 (enExample)
JPS4959787U (enExample)
JPS4913535A (enExample)
JPS48109288U (enExample)
JPS48102565A (enExample)
JPS4967478U (enExample)
CS151157B1 (enExample)
CS162177B1 (enExample)
CH589636A5 (enExample)
PL79530B1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse